Operating Income: The income after operating expenses.
REGENXBIO Inc. (RGNX) had Operating Income of $12.13M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$89.01M |
|
$6.08M |
|
$3.44M |
|
$85.58M |
|
$76.89M |
|
|
Operating Income |
$12.13M |
$-6.04M |
|
$6.08M |
|
$6.08M |
|
$6.08M |
|
$6.08M |
|
$6.08M |
|
$6.08M |
|
$12.13M |
|
$15.01M |
|
51.36M |
|
51.43M |
|
$0.12 |
|
$0.12 |
|
| Balance Sheet Financials | |
$313.24M |
|
$114.50M |
|
$177.69M |
|
$490.93M |
|
$106.73M |
|
-- |
|
$110.00M |
|
$216.73M |
|
$274.20M |
|
$274.20M |
|
$274.20M |
|
50.12M |
|
| Cash Flow Statement Financials | |
$33.63M |
|
$44.74M |
|
$-5.79M |
|
$59.56M |
|
$132.13M |
|
$72.58M |
|
$8.54M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.93 |
|
-- |
|
-- |
|
-- |
|
-- |
|
96.14% |
|
13.62% |
|
13.62% |
|
-- |
|
6.83% |
|
6.83% |
|
$32.60M |
|
-- |
|
-- |
|
-- |
|
0.18 |
|
-- |
|
4.89 |
|
18.39 |
|
2.22% |
|
2.22% |
|
1.24% |
|
2.22% |
|
$5.47 |
|
$0.63 |
|
$0.65 |
|